Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia

Table 3 Comparison of the safety of the two treatment methods

Indicators	Control group, n = 54	Research group, n = 60	χ2 value	P value
Drowsiness	4 (7.41)	1 (1.67)	-	-
Headache	4 (7.41)	1 (1.67)	-	-
Nausea	3 (5.56)	2 (3.33)	-	-
Vomiting	2 (3.70)	1 (1.67)	-	-
Memory impairment	1 (1.85)	0 (0.00)	-	-
Total	14 (25.93)	5 (8.33)	6.333	0.012

Data are presented as n (%).